MAGNEURON

Seeks to treat Parkinson’s disease by actuating the cells in our body with magnetic nanoparticles

Magneuron aims to treat Parkinson’s disease using bio-functionalised magnetic nanoparticles. These act as intracellular “hotspots” and will hijack the targeted cells’ signalling pathways in response to external magnetic fields.

MAIN THEMES:

Biotech & HealthNanotech & Materials

TOPICS:

Brainneurodegenerative disordersstem cell therapiesmagnetism

COORDINATING ORGANISATION:

Institut Curie

WEBSITE:

http://magneuron.eu/

Stories related to MAGNEURON project

Non-invasive neuromodulation techniques – A new era for the treatment of Parkinson’s disease

Biotech & Health

From optogenetics to sonogenetics to magnetognetics, scientists around the world are investigating new techniques to treat Parkinson’s disease without the need for invasive surgery

Discover more stories

Related projects

Brain Bow

Restoring neuronal connections of patients that suffered brain damage due to accidents or strokes

HELICoiD

Allowing doctors to detect cancer cells on the spot while undergoing surgery

  • FFXicon-result-patentRegistered patents
  • FFXicon-result-prototypePrototyping phase

ByAxon

Introducing less-invasive implants that treat spinal cord issues using nanomaterials

  • FFXicon-result-prototypePrototyping phase

LUMINOUS

Measures consciousness by altering electromagnetic brain stimulation

Browse all FET projects